A Preliminary Evaluation of Uptake in Bone Metastases, Biodistribution and Excretion of the Novel Radiotracer [68Ga]P15-041 by PET/CT

Trial Profile

A Preliminary Evaluation of Uptake in Bone Metastases, Biodistribution and Excretion of the Novel Radiotracer [68Ga]P15-041 by PET/CT

Recruiting
Phase of Trial: Phase 0

Latest Information Update: 08 Aug 2017

At a glance

  • Drugs P15-041 (Primary)
  • Indications Bone metastases
  • Focus Pharmacokinetics
  • Sponsors Five Eleven Pharma
  • Most Recent Events

    • 03 Aug 2017 Planned End Date changed from 1 Aug 2017 to 1 Mar 2018.
    • 03 Aug 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Sep 2017.
    • 25 Jul 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top